Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 6,552 |
| Receivables | 30 |
| Other current assets | 596 |
| TOTAL | $7,178 |
| Non-Current Assets | |
| Other Non-Current Assets | 144 |
| TOTAL | $144 |
| Total Assets | $7,322 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 223 |
| Accrued Expenses | 542 |
| TOTAL | $765 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 17,977 |
| TOTAL | $17,977 |
| Total Liabilities | $18,742 |
| Shareholders' Equity | |
| Retained earnings | -19,640 |
| TOTAL | $-11,420 |
| Total Liabilities And Equity | $7,322 |